XP Power: Mr 5000% to retire
Duncan Penny, CEO of power controller specialist XP Power (LON:XPP), has announced he is retiring at the end of the year.
Having initially joined the Group as CFO in 2000, Duncan became CEO in 2003, subsequently presiding over a 5800% growth in share price which saw XP gain entry to the FTSE 250 index earlier in the year.
XP Power designs and manufactures power controllers, the essential hardware component in every…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login
Previous article
Next article
More on Argentex Group PLC
22/01/2025 · Company Insights
A new management team is executing its plan to accelerate growth in this expert in currency risk management…
03/02/2024 · Podcasts
In this episode of the Investor’s Champion Podcast, Chris and Lee run through key news from…
More on Cake Box
12/11/2024 · Company Insights
We cover yet another takeover of a fast-growing AIM company, this time at a big premium to…
15/06/2024 · Podcasts
In this episode of the Investors Champion podcast, hosts Chris and Lee delve into several key…
More on Seeing Machines
24/12/2024 · Company Insights
The year closes with news of yet another takeover on AIM, although we can appreciate that…
12/11/2024 · Company Insights
We cover yet another takeover of a fast-growing AIM company, this time at a big premium to…
More on TPXimpact
07/02/2025 · Company Insights
News covered here includes our assessment of the latest trading update from a cosmetics group which…
29/11/2024 · Company Insights
News covered here includes our assessment of results from one of AIM’s oldest company. This well-managed business…
More on XP Power
05/10/2024 · Podcasts
In this episode of the Investors Champion Podcast, Chris and Lee discuss intriguing investment opportunities, focusing…
31/05/2024 · Podcasts
This episode of the Investor’s Champion Podcast focuses on the rampant takeover activity in the UK…
More Company Insights
This innovative legal firm continues to deliver
Encouraging news on its AI-driven platform to advance drug development
in neurological disorders
Strong growth, positive outlook and valuation remains modest
More on Argentex Group PLC
More on Cake Box
More on Seeing Machines
More on TPXimpact
More on XP Power
More Company Insights